OSUR

MKT CAP:$208M

OraSure Technologies, Inc.

Market Cap

$208M

Healthcare·Medical - Instruments & Supplies·🇺🇸 United States·NASDAQ

Healthcare·Medical·🇺🇸·NASDAQ

Stock Price

$3.05+$0.67 (+28.15%)

Apr 23, 2026

Company Details

OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices in the United States, Europe, and internationally. It operates in two segm...

CEO

Carrie Eglinton Manner

IPO Date

Nov 17, 1986

Website

www.orasure.com

Key Metrics TTM

Revenue

$126M

-43.9% YoY

Net Income

-$60M

EPS (Diluted)

-$0.80

Free Cash Flow

-$44M

Revenue / Share

$1.72

Gross Margin

37.2%

Operating Margin

-50.0%

Net Margin

-47.9%

FCF Margin

-34.7%

P/S

1.7x

P/E

—

Earnings Reports

Q4 2025

May 6, 2026

PENDING

Q3 2025

Nov 5, 2025

$27M-32.1%EPS -$0.19

Q2 2025

Aug 6, 2025

$31M-42.5%EPS -$0.26

Q1 2025

May 7, 2025

$30M-44.7%EPS -$0.21

FY 2024

Mar 7, 2025

$186M-54.2%EPS -$0.26

Revenue & Profitability

Quarter	Revenue	Gross Profit	Operating Income
Q2 21	$58M	$31M	$2M
Q3 21	$54M	$21M	-$14M
Q4 21	$64M	$27M	-$9M
Q1 22	$68M	$24M	-$16M
Q2 22	$80M	$28M	-$11M
Q1 23	$155M	$66M	$25M
Q2 23	$85M	$26M	-$6M
Q3 23	$89M	$44M	$17M
Q4 23	$76M	$36M	$8M
Q1 24	$54M	$24M	-$3M
Q2 24	$54M	$26M	-$34.0K
Q3 24	$40M	$17M	-$6M
Q4 24	$37M	$14M	-$12M
Q1 25	$30M	$11M	-$18M
Q2 25	$31M	$12M	-$17M
Q3 25	$27M	$10M	-$16M

Valuation

Quarter	P/S	P/E
Q2 21	3.2x	137.2x
Q3 21	3.4x	—
Q4 21	2.6x	—
Q1 22	2.0x	—
Q2 22	0.8x	—
Q1 23	1.2x	—
Q2 23	1.0x	—
Q3 23	1.1x	29.0x
Q4 23	1.4x	10.7x
Q1 24	1.5x	19.6x
Q2 24	1.2x	11.7x
Q3 24	1.4x	27.9x
Q4 24	1.4x	—
Q1 25	1.6x	—
Q2 25	1.6x	—
Q3 25	1.9x	—

Operating Cash Flow

Quarter	Operating CF	Free CF
Q2 21	$921.0K	-$11M
Q3 21	-$19M	-$24M
Q4 21	-$13M	-$33M
Q1 22	-$36M	-$84M
Q2 22	-$10M	-$21M
Q1 23	$6M	$2M
Q2 23	$57M	$54M
Q3 23	$37M	$35M
Q4 23	$41M	$40M
Q1 24	$7M	$5M
Q2 24	$8M	$6M
Q3 24	$13M	$13M
Q4 24	$109.0K	-$347.0K
Q1 25	-$20M	-$20M
Q2 25	-$10M	-$12M
Q3 25	-$10M	-$11M

Capital Expenditures

Quarter	CapEx
Q2 21	$12M
Q3 21	$5M
Q4 21	$21M
Q1 22	$48M
Q2 22	$11M
Q1 23	$4M
Q2 23	$3M
Q3 23	$2M
Q4 23	$1M
Q1 24	$2M
Q2 24	$2M
Q3 24	$145.0K
Q4 24	$456.0K
Q1 25	$420.0K
Q2 25	$2M
Q3 25	$919.0K

CapEx

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q2 21	+96.9%	+42.5%
Q3 21	+12.3%	+54.5%
Q4 21	+1.1%	+29.1%
Q1 22	+15.6%	+71.4%
Q2 22	+39.3%	+62.7%
Q1 23	+187.4%	+92.1%
Q2 23	+34.4%	+25.8%
Q3 23	+31.7%	-14.0%
Q4 23	-5.4%	-25.3%
Q1 24	-65.1%	-55.6%
Q2 24	-36.4%	-40.7%
Q3 24	-55.2%	-36.9%
Q4 24	-50.7%	-28.1%
Q1 25	-44.7%	-16.2%
Q2 25	-42.5%	-10.7%
Q3 25	-32.1%	-6.1%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q2 21	$1M	2.6%
Q3 21	$2M	4.1%
Q4 21	$3M	4.2%
Q1 22	$4M	5.2%
Q2 22	$3M	4.1%
Q1 23	$3M	1.7%
Q2 23	$2M	2.8%
Q3 23	$3M	2.9%
Q4 23	$3M	4.1%
Q1 24	$3M	5.5%
Q2 24	$3M	6.1%
Q3 24	$3M	7.2%
Q4 24	$3M	7.3%
Q1 25	$3M	9.0%
Q2 25	$3M	10.1%
Q3 25	$3M	10.5%

OpEx Breakdown

Quarter	R&D	SG&A
Q2 21	$8M	$21M
Q3 21	$9M	$26M
Q4 21	$9M	$28M
Q1 22	$9M	$32M
Q2 22	$9M	$29M
Q1 23	$11M	$30M
Q2 23	$8M	$25M
Q3 23	$9M	$19M
Q4 23	$7M	$21M
Q1 24	$8M	$20M
Q2 24	$6M	$19M
Q3 24	$6M	$17M
Q4 24	$6M	$19M
Q1 25	$9M	$20M
Q2 25	$11M	$18M
Q3 25	$10M	$16M

Revenue Segments

Quarter	Other Revenues	Product And Services
Q2 21	$2M	$56M
Q3 21	$688.0K	$53M
Q4 21	$2M	$61M
Q1 22	$2M	$65M
Q2 22	$1M	$79M
Q1 23	$2M	$153M
Q2 23	$703.0K	$85M
Q3 23	$173.0K	$89M
Q1 24	$353.0K	$54M
Q2 24	$386.0K	$54M
Q3 24	$264.0K	$40M
Q1 25	$934.0K	$29M
Q2 25	$1M	$30M
Q3 25	$2M	$25M

Revenue by Geography

Quarter	Europe	Other Foreign Countries	United States	Africa
Q2 21	$3M	$7M	$48M	—
Q3 21	$2M	$9M	$43M	—
Q4 21	$4M	$11M	$49M	—
Q1 22	$4M	$5M	$58M	—
Q2 22	$2M	$7M	$70M	—
Q1 23	$2M	$8M	$145M	—
Q2 23	$2M	$9M	$74M	—
Q3 23	$2M	$9M	$78M	—
Q1 24	$2M	$7M	$45M	—
Q2 24	$2M	$8M	$44M	—
Q3 24	$2M	$12M	$25M	—
Q1 25	$2M	$770.0K	$20M	$7M
Q2 25	$2M	$1M	$20M	$8M
Q3 25	$1M	$1M	$20M	$5M

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 22	$71M	$42M	$112M
Q2 22	$66M	$30M	$96M
Q3 22	$75M	$26M	$102M
Q4 22	$84M	$27M	$111M
Q1 23	$90M	$22M	$112M
Q2 23	$186M	$0	$186M
Q3 23	$218M	$7M	$225M
Q4 23	$290M	$0	$290M
Q1 24	$247M	$17M	$264M
Q2 24	$258M	$9M	$267M
Q3 24	$279M	$0	$279M
Q4 24	$268M	$0	$268M
Q1 25	$248M	$0	$248M
Q2 25	$235M	$0	$235M
Q3 25	$216M	$0	$216M
Q4 25	$199.3K	$0	$199.3K

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change	YoY Change
Q2 21	72M	-1.1%	+11.2%
Q3 21	72M	+0.1%	-0.9%
Q4 21	72M	+0.0%	-1.1%
Q1 22	72M	+0.2%	-0.8%
Q2 22	72M	+0.4%	+0.7%
Q1 23	74M	+2.0%	+2.7%
Q2 23	73M	-0.9%	+1.8%
Q3 23	74M	+1.4%	+3.0%
Q4 23	75M	+0.9%	+3.5%
Q1 24	74M	-1.4%	-0.0%
Q2 24	74M	+0.3%	+1.1%
Q3 24	75M	+0.6%	+0.3%
Q4 24	74M	-0.2%	-0.8%
Q1 25	75M	+0.6%	+1.2%
Q2 25	75M	-0.4%	+0.5%
Q3 25	73M	-2.1%	-2.1%

Shares Outstanding

Revenue Per Employee

Period	Revenue/Employee	Employees
Q2 21	$101.1K	570
Q3 21	$94.6K	570
Q4 21	$81.0K	785
Q1 22	$86.3K	785
Q2 22	$102.2K	785
Q1 23	$184.5K	840
Q2 23	$101.7K	840
Q3 23	$106.2K	840
Q4 23	$118.9K	638
Q1 24	$84.8K	638
Q2 24	$85.2K	638
Q3 24	$62.6K	638
Q4 24	$58.7K	638
Q1 25	$46.9K	638
Q2 25	$49.0K	638
Q3 25	$42.5K	638

Revenue / Employee